Gene · 2864
Papers1,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vincamine as an agonist of G protein-coupled receptor 40 effectively ameliorates pulmonary fibrosis in mice. | Phytomedicine | 2023 | 37392673 | PubTator, text mining | PubMed |
| Unveiling the MUFA-Cancer Connection: Insights from Endogenous and Exogenous Perspectives. | Int J Mol Sci | 2023 | 37373069 | PubTator, text mining | PubMed |
| Ca2+-Mediated Signaling Pathways: A Promising Target for the Successful Generation of Mature and Functional Stem Cell-Derived Pancreatic Beta Cells In Vitro. | Biomedicines | 2023 | 37371672 | PubTator, text mining | PubMed |
| G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children. | Biomedicines | 2023 | 37371671 | PubTator, text mining | PubMed |
| Editorial: Insights in endocrinology of aging: 2022. | Front Endocrinol (Lausanne) | 2023 | 37361528 | PubTator, text mining | PubMed |
| Target 2035 - an update on private sector contributions. | RSC Med Chem | 2023 | 37360399 | PubTator, text mining | PubMed |
| Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT. | Cancer Cell Int | 2023 | 37355607 | PubTator, text mining | PubMed |
| Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2. | Mol Metab | 2023 | 37348738 | PubTator, text mining | PubMed |
| Development and Characterization of Potent Succinate Receptor Fluorescent Tracers. | J Med Chem | 2023 | 37318348 | PubTator, text mining | PubMed |
| Interkingdom Detection of Bacterial Quorum-Sensing Molecules by Mammalian Taste Receptors. | Microorganisms | 2023 | 37317269 | PubTator, text mining | PubMed |
| Disease-Modifying Effects of Vincamine Supplementation in Drosophila and Human Cell Models of Parkinson's Disease Based on DJ-1 Deficiency. | ACS Chem Neurosci | 2023 | 37289979 | PubTator, text mining | PubMed |
| FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB. | Cell Biosci | 2023 | 37287005 | PubTator, text mining | PubMed |
| Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development. | Pharmaceuticals (Basel) | 2023 | 37259459 | PubTator, text mining | PubMed |
| Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? | iScience | 2023 | 37250301 | PubTator, text mining | PubMed |
| G Protein-Coupled Receptor 75 (GPR75) As a Novel Molecule for Targeted Therapy of Cancer and Metabolic Syndrome. | Asian Pac J Cancer Prev | 2023 | 37247305 | PubTator, text mining | PubMed |
| Intestinal Enteroendocrine Cells: Present and Future Druggable Targets. | Int J Mol Sci | 2023 | 37240181 | PubTator, text mining | PubMed |
| Reduced Expression of Very-Long-Chain Acyl-CoA Synthetases SLC27A4 and SLC27A6 in the Glioblastoma Tumor Compared to the Peritumoral Area. | Brain Sci | 2023 | 37239243 | PubTator, text mining | PubMed |
| A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer. | Front Mol Biosci | 2023 | 37228586 | PubTator, text mining | PubMed |
| Molecular mechanism of fatty acid activation of FFAR1. | Proc Natl Acad Sci U S A | 2023 | 37216523 | PubTator, text mining | PubMed |
| TYROBP-positive endothelial cell-derived TWEAK as a promoter of osteosarcoma progression: insights from single-cell omics. | Front Oncol | 2023 | 37207157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2864/papers?page=9